Literature DB >> 28638491

O-GlcNAc-ylation in the Nuclear Pore Complex.

Andrew Ruba1, Weidong Yang1.   

Abstract

O-GlcNAc-ylation is the post-translational addition of an O-linked β-N-acetylglucosamine to the serine and threonine residues of thousands of proteins in eukaryotic cells. Specifically, half of the thirty different types of protein components in the nuclear pore complex (NPC) are modified by O-GlcNAc, of which the majority are intrinsically disordered nucleoporins (Nups) containing multiple phenylalanine-glycine (FG) repeats. Moreover, these FG-Nups form a strict selectivity barrier with a high density of O-GlcNAc in the NPC to mediate bidirectional trafficking between the cytoplasm and nucleus. However, the roles that O-GlcNAc plays in the structure and function of the NPC remain obscure. In this review paper, we will discuss the current knowledge of O-GlcNAc-ylated Nups, highlight some new techniques used to probe O-GlcNAc's roles in the nuclear pore, and finally propose a new model for the effect of O-GlcNAc on the NPC's permeability.

Entities:  

Keywords:  glycosylation; nuclear pore complex; nucleoporins

Year:  2016        PMID: 28638491      PMCID: PMC5475274          DOI: 10.1007/s12195-016-0440-0

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  70 in total

1.  Kinetic analysis of translocation through nuclear pore complexes.

Authors:  K Ribbeck; D Görlich
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells.

Authors:  Natasha E Zachara; Niall O'Donnell; Win D Cheung; Jessica J Mercer; Jamey D Marth; Gerald W Hart
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

Review 3.  Proteomics of the Synapse--A Quantitative Approach to Neuronal Plasticity.

Authors:  Daniela C Dieterich; Michael R Kreutz
Journal:  Mol Cell Proteomics       Date:  2015-08-25       Impact factor: 5.911

4.  Reconstitution of biochemically altered nuclear pores: transport can be eliminated and restored.

Authors:  D R Finlay; D J Forbes
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

5.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 6.  Structure, dynamics and function of nuclear pore complexes.

Authors:  Maximiliano A D'Angelo; Martin W Hetzer
Journal:  Trends Cell Biol       Date:  2008-09-09       Impact factor: 20.808

7.  Characterization of the specificity of O-GlcNAc reactive antibodies under conditions of starvation and stress.

Authors:  Russell A Reeves; Albert Lee; Roger Henry; Natasha E Zachara
Journal:  Anal Biochem       Date:  2014-04-18       Impact factor: 3.365

8.  A chemical approach for identifying O-GlcNAc-modified proteins in cells.

Authors:  David J Vocadlo; Howard C Hang; Eun-Ju Kim; John A Hanover; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

9.  Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling.

Authors:  Shuai Wang; Xun Huang; Danni Sun; Xianliang Xin; Qiuming Pan; Shuying Peng; Zhongjie Liang; Cheng Luo; Yiming Yang; Hualiang Jiang; Min Huang; Wengang Chai; Jian Ding; Meiyu Geng
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

10.  Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine.

Authors:  G D Holt; C M Snow; A Senior; R S Haltiwanger; L Gerace; G W Hart
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  7 in total

1.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

2.  Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteins.

Authors:  Clifford A Toleman; Maria A Schumacher; Seok-Ho Yu; Wenjie Zeng; Nathan J Cox; Timothy J Smith; Erik J Soderblom; Amberlyn M Wands; Jennifer J Kohler; Michael Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

3.  Mutant Huntingtin Disrupts the Nuclear Pore Complex.

Authors:  Jonathan C Grima; J Gavin Daigle; Nicolas Arbez; Kathleen C Cunningham; Ke Zhang; Joseph Ochaba; Charlene Geater; Eva Morozko; Jennifer Stocksdale; Jenna C Glatzer; Jacqueline T Pham; Ishrat Ahmed; Qi Peng; Harsh Wadhwa; Olga Pletnikova; Juan C Troncoso; Wenzhen Duan; Solomon H Snyder; Laura P W Ranum; Leslie M Thompson; Thomas E Lloyd; Christopher A Ross; Jeffrey D Rothstein
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

4.  Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins.

Authors:  Senhan Xu; Ming Tong; Suttipong Suttapitugsakul; Ronghu Wu
Journal:  Cell Rep       Date:  2022-06-14       Impact factor: 9.995

5.  Truncation of the TPR domain of OGT alters substrate and glycosite selection.

Authors:  Daniel H Ramirez; Bo Yang; Alexandria K D'Souza; Dacheng Shen; Christina M Woo
Journal:  Anal Bioanal Chem       Date:  2021-11-02       Impact factor: 4.142

6.  Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation.

Authors:  Xianhui Liu; Ivana Blaženović; Adam J Contreras; Thu M Pham; Christine A Tabuloc; Ying H Li; Jian Ji; Oliver Fiehn; Joanna C Chiu
Journal:  Nat Commun       Date:  2021-07-07       Impact factor: 14.919

Review 7.  Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.

Authors:  Sarah J Tabrizi; Michael D Flower; Christopher A Ross; Edward J Wild
Journal:  Nat Rev Neurol       Date:  2020-08-14       Impact factor: 42.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.